Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial

An amendment to this paper has been published and can be accessed via the original article.

Bibliographic Details
Main Authors: Javed Akram, Shehnoor Azhar, Muhammad Shahzad, Waqas Latif, Khalid Saeed Khan
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Trials
Online Access:http://link.springer.com/article/10.1186/s13063-020-04697-1
id doaj-89b8091f08a34308a6543b948122a44f
record_format Article
spelling doaj-89b8091f08a34308a6543b948122a44f2020-11-25T03:40:18ZengBMCTrials1745-62152020-08-012111110.1186/s13063-020-04697-1Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trialJaved Akram0Shehnoor Azhar1Muhammad Shahzad2Waqas Latif3Khalid Saeed Khan4Vice Chancellor/Professor of Internal Medicine, University of Health SciencesAssistant Professor Public Health, University of Health SciencesProfessor of Pharmacology, University of Health SciencesData Analyst at University of Health SciencesDistinguished Investigator at Department of Preventive Medicine and Public Health, University of GranadaAn amendment to this paper has been published and can be accessed via the original article.http://link.springer.com/article/10.1186/s13063-020-04697-1
collection DOAJ
language English
format Article
sources DOAJ
author Javed Akram
Shehnoor Azhar
Muhammad Shahzad
Waqas Latif
Khalid Saeed Khan
spellingShingle Javed Akram
Shehnoor Azhar
Muhammad Shahzad
Waqas Latif
Khalid Saeed Khan
Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial
Trials
author_facet Javed Akram
Shehnoor Azhar
Muhammad Shahzad
Waqas Latif
Khalid Saeed Khan
author_sort Javed Akram
title Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial
title_short Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial
title_full Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial
title_fullStr Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial
title_full_unstemmed Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial
title_sort correction to: pakistan randomized and observational trial to evaluate coronavirus treatment (protect) of hydroxychloroquine, oseltamivir and azithromycin to treat newly diagnosed patients with covid-19 infection: a structured summary of a study protocol for a randomized controlled trial
publisher BMC
series Trials
issn 1745-6215
publishDate 2020-08-01
description An amendment to this paper has been published and can be accessed via the original article.
url http://link.springer.com/article/10.1186/s13063-020-04697-1
work_keys_str_mv AT javedakram correctiontopakistanrandomizedandobservationaltrialtoevaluatecoronavirustreatmentprotectofhydroxychloroquineoseltamivirandazithromycintotreatnewlydiagnosedpatientswithcovid19infectionastructuredsummaryofastudyprotocolforarandomizedcontrolledtrial
AT shehnoorazhar correctiontopakistanrandomizedandobservationaltrialtoevaluatecoronavirustreatmentprotectofhydroxychloroquineoseltamivirandazithromycintotreatnewlydiagnosedpatientswithcovid19infectionastructuredsummaryofastudyprotocolforarandomizedcontrolledtrial
AT muhammadshahzad correctiontopakistanrandomizedandobservationaltrialtoevaluatecoronavirustreatmentprotectofhydroxychloroquineoseltamivirandazithromycintotreatnewlydiagnosedpatientswithcovid19infectionastructuredsummaryofastudyprotocolforarandomizedcontrolledtrial
AT waqaslatif correctiontopakistanrandomizedandobservationaltrialtoevaluatecoronavirustreatmentprotectofhydroxychloroquineoseltamivirandazithromycintotreatnewlydiagnosedpatientswithcovid19infectionastructuredsummaryofastudyprotocolforarandomizedcontrolledtrial
AT khalidsaeedkhan correctiontopakistanrandomizedandobservationaltrialtoevaluatecoronavirustreatmentprotectofhydroxychloroquineoseltamivirandazithromycintotreatnewlydiagnosedpatientswithcovid19infectionastructuredsummaryofastudyprotocolforarandomizedcontrolledtrial
_version_ 1724534931938344960